X0704 D LIVE 0001100397 Advaxis, Inc. 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 609-452-9813 DELAWARE Great Expectations and Associates, Inc. GREAT EXPECTATIONS & ASSOCIATES INC Corporation true Thomas Moore 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Executive Officer Director James Patton 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Director Roni A. Appel 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Director Thomas McKearn 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Director Richard Berman 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Director John Rothman 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Executive Officer Mark J. Rosenblum 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Executive Officer Biotechnology Decline to Disclose 06 false 2012-01-09 false true true true true Common Stock issuable upon conversion of notes. false 0 Rodman & Renshaw, LLC 16415 None None 1251 AVENUE OF THE AMERICAS 20TH FLOOR NEW YORK NY NEW YORK 10020 CA CALIFORNIA CT CONNECTICUT GA GEORGIA IL ILLINOIS NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA PA PENNSYLVANIA false Indefinite 1047500 Indefinite Advaxis, Inc. received an aggregate purchase price of $1,047,500.00 in return for issuing to the investors (i) an aggregate of $1,232,352.94 of its convertible promissory notes and (ii) warrants to purchase up to 4,107,842 shares of its common stock. false 12 73325 0 Rodman & Renshaw, LLC also received warrants to purchase an aggregate of 575,098 shares of Advaxis, Inc.'s common stock as part of its sales commission. 0 No amount of the gross proceeds is anticipated to pay named executive officers, except that the issuer may use up to $200,000 of the gross proceeds or other available funds for payments to its CEO for prior outstanding amounts owed to him. false Advaxis, Inc. /s/ Mark J. Rosenblum Mark J. Rosenblum Chief Financial Officer, Senior Vice President and Secretary 2012-02-24